2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …

Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …

A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives

M Evans, RD Lewis, AR Morgan, MB Whyte, W Hanif… - Advances in …, 2022 - Springer
Chronic kidney disease (CKD) is a complex disease which affects approximately 13% of the
world's population. Over time, CKD can cause renal dysfunction and progression to end …

[PDF][PDF] US renal data system 2021 annual data report: epidemiology of kidney disease in the United States

KL Johansen, GM Chertow, DT Gilbertson… - American Journal of …, 2022 - Elsevier
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the
United States Page 1 EXECUTIVE SUMMARY <LRH>Johansen et al <DOC>Executive …

Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China

F Xiong, H Tang, L Liu, C Tu, JB Tian… - Journal of the …, 2020 - journals.lww.com
Background Reports indicate that those most vulnerable to developing severe coronavirus
disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as …

Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway

H Ren, Y Shao, C Wu, X Ma, C Lv, Q Wang - Molecular and cellular …, 2020 - Elsevier
Metformin, as the basic pharmacological therapy and the first preventive drug in type 2
diabetes mellitus (T2DM), is proved to have potential protection in diabetic kidney disease …

APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease

S Datta, BM Antonio, NH Zahler… - The Journal of …, 2024 - Am Soc Clin Investig
Two coding variants of apolipoprotein L1 (APOL1), called G1 and G2, explain much of the
excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have …

Inflammation in renal diseases: new and old players

V Andrade-Oliveira, O Foresto-Neto… - Frontiers in …, 2019 - frontiersin.org
Inflammation, a process intimately linked to renal disease, can be defined as a complex
network of interactions between renal parenchymal cells and resident immune cells, such as …

Diabetic kidney diseases revisited: A new perspective for a new era

H Fu, S Liu, SI Bastacky, X Wang, XJ Tian, D Zhou - Molecular metabolism, 2019 - Elsevier
Background Globally, diabetic kidney disease (DKD) is the leading cause of end-stage renal
disease. As the most common microvascular complication of diabetes, DKD is a thorny …

Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease

PR Pereira, DF Carrageta, PF Oliveira… - Medicinal Research …, 2022 - Wiley Online Library
Diabetic kidney disease (DKD) is one of the most prevalent comorbidities of diabetes
mellitus and the leading cause of the end‐stage renal disease (ESRD). DKD results from …

Intestinal microbiome and fitness in kidney disease

B Meijers, P Evenepoel, HJ Anders - Nature reviews nephrology, 2019 - nature.com
Environmental changes can induce diversity shifts within ecosystems that affect interactions
between species. Similarly, the development of kidney disease induces shifts within the …